
Overview
EXIM Pharma provides contract manufacturing of dietary supplements, medical devices and nutritional products for people and animals, including private-label brands. Its range includes probiotics in drops and capsules, vitamins, herbal preparations, tablets, hard and soft capsules, and hard capsules with liquid fillings. Products are made from customer-supplied recipes or the company’s own formulas, with additional services including encapsulation, tableting, coating, and product notification and registration.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $970,721 |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 90 days for 2021). 4 of 6 audited by a statutory auditor.
- 202519/06/2026
- 202410/07/2025
- 202311/07/2024
- 202229/08/2023
- 202113/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Medical devices
- Contract manufacturing
- Capsule production
- Tablet production
- Syrup manufacturing
- Laboratory testing
- Product packaging
Websites
The site is available in: Polish and English.
- eximpharma.euProducent suplementów diety, odżywek i wyrobów medycznych | Exim PharmaWooCommerceWordPress 3.7Google AnalyticsGoogle Tag ManagerYoast SEOLLiteSpeed
Trademarks
The company holds 6 active trademarks registered with the Polish Patent Office. The first mark was filed in 2016.
| Mark | Protected until | |
|---|---|---|
| HERBISOUL | Feb 1, 2033 | |
| proMUM | Jun 15, 2031 | |
| exim pharma LABORATORIES Goodvit | Apr 10, 2029 | |
| Rainbovit baby DIETARY SUPPLEMENT | May 15, 2028 | |
| VigoONE XL men’s sexual health dietary supplement | May 15, 2028 |
Job offers
The company lists 6 job openings on its own careers page: eximpharma.eu/praca.
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sunday Natural Products Gmbh | 2,000 | $27,012.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2015-12-10.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $611.7K$611,737 |
Buildings and premises | $4M$3,974,302 |
Public aid
19 public aid cases recorded, with a total value of $1,402,769.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2025 | Regional investment aid | $206.7K$206,710 | DRUGI MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE | |
| May 7, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $858$858 | STAROSTA POWIATU WĘGRÓW | |
| Apr 24, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,253$2,253 | STAROSTA POWIATU WĘGRÓW |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-07-01 | Promotion of Exim Pharma in foreign markets in connection with Poland’s participation in Expo 2020 | $56,907$56,907 | Operational Programme Smart Growth | |
| 2018-04-30 | Development of EXIM PHARMA through promotion in international markets. | $87,120$87,120 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prosuplement Group sp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Curtis Health Caps S.A. | $34,513,094.78 | chc.com.pl | ||
| Efferta Pharma sp. z o.o. | $33,051,786.19 | efferta.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Global Pharma Cm S.A. | $24,132,016.98 | globalpharma.pl | ||
| Master Pharm S.A. | $23,116,954.19 | masterpharm.pl | ||
| Europharma Alliance sp. z o.o. | $15,439,864.68 | pharmaalliance.eu | ||
| Valentis Polska sp. z o.o. | $13,271,939.35 | valentis.pl | ||
| Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o. | $10,474,927.81 | ichem.com.pl | ||
| Medicofarma S.A. | $8,530,473.72 | medicofarma.pl |
FAQ
Last updated: 2026-10-07
